PATENT CLAIM ANALYSIS

Application Number: 15878142
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "355000"]

Abstract:
The invention relates to Substituted-Quinoxaline-Type Bridged-Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.

Claim (Index 47):
A method for treating pain in an animal, comprising administering to an animal in need thereof an effective amount of a compound of Formula (I\u2032): or a pharmaceutically acceptable derivative thereof, wherein:\n each R 2  is independently selected from -halo; \n a is 0, 1 or 2; \n b is 0 or 1; \n each R 5  is independently \u2014H, \u2014OH, \u2014(C 1 -C 3 )alkyl, \u2014C(halo) 3 , or -halo; \n R 1  is \u2014(C 9 -C 14 )cycloalkyl or \u2014(C 9 -C 14 )bicycloalkyl, each of which is substituted with 1, 2 or 3 independently selected R 3  groups; \n each R 3  is independently \u2014(C 1 -C 4 )alkyl, \u2014(C 2 -C 6 )alkenyl, \u2014(C 2 -C 6 )alkynyl, or \u2014(C 3 -C 6 )cycloalkyl.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.54839
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13915204', '14859139', '13996440', '15041998', '14331034']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7520257319232613
- 35 USC 102 Novelty (BERT): 0.5312874480859912
- Combined Prediction Score: 0.7299519035395342
- Mean Citation Score: 333.78154200000006
- Max Citation Score: 359.33118
- Similarity Product: 320.31144754579066

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test